BeStock  
Markets › Compare › ABSI vs ABCL

ABSI vs ABCL

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
ABSI · Absci Corp$7.51 ▼ 7.97%
ABCL · AbCellera Biologics$9.69 ▼ 7.45%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

57152246341435Nov 24, '25May 26, '26Nov 20, '26
  • ABSI +153.7%
  • ABCL +171.4%

Head to head

MetricABSIABCL
Price$7.51$9.69
Change today▼ 7.97%▼ 7.45%
Market cap$1.30B$3.16B
Return, 3 months-15.0%-8.7%
Return, year to date+115.2%+183.3%
Return, 1 year+156.3%+176.1%
P/E (TTM)––
P/B5.93.0
P/E percentile vs own 5y6th6th
Dividend yield––
Revenue growth (YoY, latest qtr)-19.6%+18.8%
Net profit growth (YoY)-16.0%+28.6%
Gross margin––
Operating margin-9,155.3%-275.7%
Net margin-8,451.3%-218.6%
Return on equity-58.6%-14.6%
Analyst target vs. price+96.4%+99.5%
Analyst buy share89%89%
RSI (14)3934
30-day volatility118.1%80.2%
Max drawdown, 1 year-42.8%-40.1%
Trend readLeaning bearishLeaning bearish
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • ABCL is the largest of the group by market value.
  • ABCL has returned the most over the past year.
  • ABCL is growing revenue fastest.
  • ABCL keeps the most profit per dollar of sales.
  • ABCL has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top